Singer Charity Sunshine Tillemann-Dick Passed Away From Pulmonary Arterial Hypertension at Age 35

According to a story from radio.wpsu.org, soprano singer Charity Sunshine Tillemann-Dick recently passed away at the young age of 35 because of pulmonary arterial hypertension, a rare condition of increased…

Continue Reading Singer Charity Sunshine Tillemann-Dick Passed Away From Pulmonary Arterial Hypertension at Age 35

New Drug Has Promise for Treating Diffuse Intrinsic Pontine Glioma and Fibrodysplasia Ossificans Progressiva

Diffuse Intrinsic Pontine Glioma Diffuse intrinsic pontine glioma (DIPG) is a rare form of childhood brain cancer that has a 100% mortality rate. Children diagnosed with DIPG only typically live…

Continue Reading New Drug Has Promise for Treating Diffuse Intrinsic Pontine Glioma and Fibrodysplasia Ossificans Progressiva
Innovative New Test Could Allow for Inflammatory Bowel Disease Patients to Receive More Personalized Treatment
WolfBlur / Pixabay

Innovative New Test Could Allow for Inflammatory Bowel Disease Patients to Receive More Personalized Treatment

According to a story from EurekAlert!, a team of scientists affiliated with the University of Cambridge have pioneered a new test that could herald a new development in the treatment…

Continue Reading Innovative New Test Could Allow for Inflammatory Bowel Disease Patients to Receive More Personalized Treatment
As Gene Therapy Becomes a Reality, Spark Therapeutics Looks at Challenges That Still Remain
geralt / Pixabay

As Gene Therapy Becomes a Reality, Spark Therapeutics Looks at Challenges That Still Remain

According to a story from BioPharma Dive, the advent of gene therapy development at Spark Therapeutics has been five years in the making. At this juncture, it has been nearly…

Continue Reading As Gene Therapy Becomes a Reality, Spark Therapeutics Looks at Challenges That Still Remain
Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light
WikimediaImages / Pixabay

Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light

According to a story from BioSpace, the drug development company Dynacure recently released an announcement in which the company stated that its application for a Phase 1/2 clinical trial had…

Continue Reading Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light
New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications
ColiN00B / Pixabay

New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications

A recent report that was published in the Swiss Medical Weekly outlines data gathered by a Swiss panel of experts on plasma cell myeloma. The report offers an update and…

Continue Reading New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications
Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?
NeuPaddy / Pixabay

Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?

According to a story from fox43.com, an experimental therapy for the genetic form of amyotrophic lateral sclerosis (ALS) has been termed "game changing." A study that will soon be presented…

Continue Reading Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?

Drink One For Dane: Dutch Bros Coffee Hosts 13th Annual Amyotrophic Lateral Sclerosis Fundraiser This Friday, May 10th

Dutch Bros Coffee is hosting their 13th annual fundraiser for amyotrophic lateral sclerosis (ALS) this Friday, May 10th, 2019. It's called "Drink One for Dane" in honor of Dane Boersma,…

Continue Reading Drink One For Dane: Dutch Bros Coffee Hosts 13th Annual Amyotrophic Lateral Sclerosis Fundraiser This Friday, May 10th

Finding an Effective Personalized Therapy for Mastocytosis can be Frustrating, but it is Possible

What Exactly is Mast Cell Disease According to The Mastocytosis Society (TMS), there are three forms of mast cell disease. All involve the malfunction or over-development of mast cells in…

Continue Reading Finding an Effective Personalized Therapy for Mastocytosis can be Frustrating, but it is Possible
Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All
skeeze / Pixabay

Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All

According to a story from The Intercept, Ady Barkan's life is slowly slipping away as his amyotrophic lateral sclerosis continues to progress. Despite this, Ady has developed a reputation as…

Continue Reading Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All
Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US
geralt / Pixabay

Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US

According to a story from Lambert-Eaton News, a recent large scale study using data from the Veterans Affairs has determined that the prevalence of Lambert-Eaton myasthenic syndrome (LEMS) is similar…

Continue Reading Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US
Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?
qimono / Pixabay

Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

According to a story from globenewswire.com, the biopharmaceutical company Innovation Pharmaceuticals recently released a report in which recent studies and pre-clinical research has suggested that the company's experimental drug Kevetrin…

Continue Reading Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?